Insmed

Forecast & Rating23 analysts currently cover Insmed, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $196.18, about 88.4% upside from the current price of $104.13. Price targets range from $140.00 to $243.00 — a wide spread, showing clear disagreement over just how much Insmed can rise. Historically, about 54.4% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Insmed closely still see room for the stock to rise. Data as of Jul 28, 2026; for reference only and not investment advice.